Drug Shortage Report for DEXTROSE INJECTION USP
Report ID | 147420 |
Drug Identification Number | 00037974 |
Brand name | DEXTROSE INJECTION USP |
Common or Proper name | Dextrose Injection USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 500MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mL in 1000 mL |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-02-02 |
Actual start date | |
Estimated end date | 2022-02-28 |
Actual end date | 2021-11-02 |
Shortage status | Avoided shortage |
Updated date | 2021-11-02 |
Company comments | Shortage avoided. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-11-02 | French | Compare |
v3 | 2021-11-02 | English | Compare |
v2 | 2021-10-15 | French | Compare |
v1 | 2021-10-15 | English | Compare |
Showing 1 to 4 of 4